Identification of methylation-associated gene expression in neuroendocrine pancreatic tumor cells

Pancreatology

Volumn 7, Issue 4, 2007, Pages 352-359

  Habbe, Nils ^a   Bert, Tillmann ^a   Simon, Babette ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Carcinoid; Epigenetics; Methylation; Neuroendocrine tumor; Pancreas

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; COFILIN; COMPLEMENTARY DNA; MATRIPTASE;

ARTICLE; CARCINOGENESIS; DNA METHYLATION; GENE EXPRESSION; NEUROENDOCRINE TUMOR; NUCLEOTIDE SEQUENCE; PANCREAS TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE;

EID: 34748849494     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000107270     Document Type: Article

References (29)

1. Godwin JD 2nd: Carcinoid tumors: an analysis of 2,837 cases. Cancer 1975;36:560-569.
2. Chan AO, Kim SG, Bedeir A, Issa JP, Hamilton SR, Rashid A: CpG island methylation in carcinoid and pancreatic endocrine tumors. Oncogene 2003;22:924-934.
3. Jones PA, Baylin SB: The epigenomics of cancer. Cell 2007;128:683-692.
4. Feinberg AP, Tycko B: The history of cancer epigenetics. Nat Rev Cancer 2004;4:143-153.
5. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-428.
6. Ting AH, McGarvey KM, Baylin SB: The cancer epigenome: components and functional correlates. Genes Dev 2006;20:3215-3231.
7. Jones PA, Laird PW: Cancer epigenetics comes of age. Nat Genet 1999;21:163-167.
8. Esteller M, Corn PG, Baylin SB, Herman JG: A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-3229.
9. Ehrlich M: DNA methylation in cancer: too much, but also too little. Oncogene 2002;21:5400-5413.
10. Esteller M: CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002;21:5427-5440.
11. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R: DNA hypomethylation leads to elevated mutation rates. Nature 1998;395:89-93.
12. Eden A, Gaudet F, Waghmare A, Jaenisch R: Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003;300:455.
13. Feinberg AP, Ohlsson R, Henikoff S: The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006;7:21-33.
14. Herman JG, Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-2054.
15. Callinan PA, Feinberg AP: The emerging science of epigenomics. Hum Mol Genet 2006;15(suppl 1):R95-R101.
16. Lubomierski N, Kersting M, Bert T, Muench K, Wulbrand U, Schuermann M, Bartsch D, Simon B: Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors. Cancer Res 2001;61:5905-5910.
17. Iliopoulos D, Fabbri M, Druck T, Qin HR, Han SY, Huebner K: Inhibition of breast cancer cell growth in vitro and in vivo: effect of restoration of Wwox Expression. Clin Cancer Res 2007;13:268-274.
18. Hubank M, Schatz DG: cDNA representational difference analysis: a sensitive and flexible method for identification of differentially expressed genes. Methods Enzymol 1999;303:325-349.
19. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000;100:57-70.
20. Ding SJ, Li Y, Shao XX, Zhou H, Zeng R, Tang ZY, Xia QC: Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials. Proteomics 2004;4:982-994.
21. Wang W, Mouneimne G, Sidani M, Wyckoff J, Chen X, Makris A, Goswami S, Bresnick AR, Condeelis JS: The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol 2006;173:395-404.
22. Yap CT, Simpson TI, Pratt T, Price DJ, Maciver SK: The motility of glioblastoma tumour cells is modulated by intracellular cofilin expression in a concentration-dependent manner. Cell Motil Cytoskeleton 2005;60:153-165.
23. Cecconi D, Astner H, Donadelli M, Palmieri M, Missiaglia E, Hamdan M, Scarpa A, Righetti PG: Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2′-deoxycytidine. Electrophoresis 2003;24:4291-4303.
24. Ahn JY, Rong R, Kroll TG, Van Meir EG, Snyder SH, Ye K: PIKE (phosphatidylinositol 3-kinase enhancer)-A GTPase stimulates Akt activity and mediates cellular invasion. J Biol Chem 2004;279:16441-16451.
25. Uhland K: Matriptase and its putative role in cancer. Cell Mol Life Sci 2006;63:2968-2978.
26. Suzuki M, Kobayashi H, Kanayama N, Saga Y, Suzuki M, Lin CY, Dickson RB, Terao T: Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase. J Biol Chem 2004 Apr 9;279:14899-14908.
27. List K, Szabo R, Molinolo A, Sriuranpong V, Redeye V, Murdock T, Bure B, Nielsen BS, Gutkind JS, Bugge TH: Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev 2005;19:1934-1950.
28. Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Y, Aung PP, Kuraoka K, Nakayama H, Yasui W: Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 2004;64:2397-2405.
29. Esteller M: DNA methylation and cancer therapy: new developments and expectations. Curr Opin Oncol 2005;17:55-60.